Depatuxizumab mafodotin
- Generic Name
- Depatuxizumab mafodotin
- Drug Type
- Biotech
- CAS Number
- 1585973-65-4
- Unique Ingredient Identifier
- F3R7A4P04N
- Background
Depatuxizumab/Denintuzumab mafodotin has been used in trials studying the treatment of Lymphoma, Gliosarcoma, Glioblastoma, Malignant Glioma, Squamous Cell Tumors, and Glioblastoma Multiforme.
- Indication
No approved indication.
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath